209 related articles for article (PubMed ID: 6712367)
21. Increase in serum-lipids during treatment of hypertension with chlorthalidone.
Ames RP; Hill P
Lancet; 1976 Apr; 1(7962):721-3. PubMed ID: 56536
[TBL] [Abstract][Full Text] [Related]
22. [Spironolactone combined with chlorthalidone in the treatment of essential arterial hypertension].
Gragnoli G; Puccetti F; Tanganelli I; Favilli R; Nami R
Minerva Med; 1975 Apr; 66(30):1412-6. PubMed ID: 1143685
[TBL] [Abstract][Full Text] [Related]
23. [The behavior of uricemia during treatment with spironolactone and with other diuretics].
Bufalari A; Meloni G
Minerva Med; 1967 Nov; 58(89):3815-22. PubMed ID: 6074933
[No Abstract] [Full Text] [Related]
24. Chlorthalidone - a renaissance in use?
Sica DA
Expert Opin Pharmacother; 2009 Sep; 10(13):2037-9. PubMed ID: 19663607
[TBL] [Abstract][Full Text] [Related]
25. Differential effects of chlorthalidone versus spironolactone on muscle sympathetic nerve activity in hypertensive patients.
Menon DV; Arbique D; Wang Z; Adams-Huet B; Auchus RJ; Vongpatanasin W
J Clin Endocrinol Metab; 2009 Apr; 94(4):1361-6. PubMed ID: 19158191
[TBL] [Abstract][Full Text] [Related]
26. [Indapamide--a substitute diuretic for hypertensives with hyperglycemia and/or dyslipidemia].
Sharabi Y; Grossman E; Nussinovitch N; Katz A; Rachima-Moaz C; Rosenthal T
Harefuah; 1996 Oct; 131(7-8):233-6, 295. PubMed ID: 8940516
[TBL] [Abstract][Full Text] [Related]
27. Lability of serum low-density lipoprotein cholesterol levels during screening in subgroup of Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) cohort.
Clearfield MB; Weis SE; Willis JM; Vasenius KA; McConathy WJ
J Am Osteopath Assoc; 2002 Jul; 102(7):377-84. PubMed ID: 12138952
[TBL] [Abstract][Full Text] [Related]
28. Hypokalemia during the treatment of arterial hypertension with diuretics.
Lemieux G; Beauchemin M; Vinay P; Gougoux A
Can Med Assoc J; 1980 Apr; 122(8):905-7. PubMed ID: 7370875
[TBL] [Abstract][Full Text] [Related]
29. Serum lipoprotein levels during chlorthalidone therapy. A Veterans Administration-National Heart, Lung, and Blood Institute cooperative study on antihypertensive therapy: mild hypertension.
Goldman AI; Steele BW; Schnaper HW; Fitz AE; Frohlich ED; Perry HM
JAMA; 1980 Oct; 244(15):1691-5. PubMed ID: 6997522
[TBL] [Abstract][Full Text] [Related]
30. Comparison of chlorthalidone, propranolol and bopindolol in six-month treatment of arterial hypertension.
Bagatin J; Sardelić S; Pivac N; Polić S; Ljutic D; Rakic D; Naranca M; Bojić L; Kovacić Z; Rumboldt Z
Int J Clin Pharmacol Res; 1998; 18(2):73-8. PubMed ID: 9675624
[TBL] [Abstract][Full Text] [Related]
31. [Lipid distribution in the adult population of Catalonia].
Plans P; Ruigómez J; Pardell H; Salleras L
Rev Clin Esp; 1993 Jun; 193(1):35-42. PubMed ID: 8337460
[TBL] [Abstract][Full Text] [Related]
32. [Respective roles of hemodynamic or humoral factors and of hypotensive or salidiuretic drugs in the development of essential hypertension].
Froment R; Froment A; Zech P
Pathol Biol; 1965 Nov; 13(21):1094-102. PubMed ID: 4875799
[No Abstract] [Full Text] [Related]
33. Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
Davis BR; Piller LB; Cutler JA; Furberg C; Dunn K; Franklin S; Goff D; Leenen F; Mohiuddin S; Papademetriou V; Proschan M; Ellsworth A; Golden J; Colon P; Crow R;
Circulation; 2006 May; 113(18):2201-10. PubMed ID: 16651474
[TBL] [Abstract][Full Text] [Related]
34. [Is antihypertensive treatment a risk factor of coronary disease? Therapy-related triglyceride increase nor diabetes increase the risk].
Samuelsson O; Pennert K; Andersson O; Berglund G; Hedner T; Persson B; Wedel H; Wilhelmsen L
Lakartidningen; 1998 Mar; 95(11):1120-3. PubMed ID: 9542820
[TBL] [Abstract][Full Text] [Related]
35. [All diuretics used in the treatment of hypertension are not the same].
Asil S; Atalar E
Turk Kardiyol Dern Ars; 2017 Jan; 45(1):94-101. PubMed ID: 28106027
[TBL] [Abstract][Full Text] [Related]
36. Which diuretic is the preferred agent for treating essential hypertension: hydrochlorothiazide or chlorthalidone?
Germino FW
Curr Cardiol Rep; 2012 Dec; 14(6):673-7. PubMed ID: 22918623
[TBL] [Abstract][Full Text] [Related]
37. [A comparative study of spironolactone and chlorthalidone in treatment of hypertension].
Fagerberg SE; Göransson K
Lakartidningen; 1974 Jan; 71(3):175-7. PubMed ID: 4837216
[No Abstract] [Full Text] [Related]
38. [Objectives and methods in therapy of essential arterial hypertension].
Zanchetti A
Cardiol Prat; 1968 Aug; 19(4):263-6. PubMed ID: 5746811
[No Abstract] [Full Text] [Related]
39. Increased serum low-density lipoprotein cholesterol in men treated short-term with the diuretic chlorthalidone.
Glück Z; Weidmann P; Mordasini R; Bachmann C; Riesen W; Peheim E; Keusch G; Meier A
Metabolism; 1980 Mar; 29(3):240-5. PubMed ID: 7374438
[TBL] [Abstract][Full Text] [Related]
40. Chlorthalidone plus reserpine versus hydrochlorothiazide plus reserpine in a stepped-care approach to the treatment of essential hypertension.
Finnerty FA
J Clin Pharmacol; 1980; 20(5-6 Pt 1):357-63. PubMed ID: 7400374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
